# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Neuromyelitis optica spectrum disorder

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 19 results.
A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders
Status: Not yet recruiting
Last Changed: Oct 31, 2019
First Received: Oct 31, 2019
Disease(s): Neuromyelitis Optica Spectrum Disorders
Intervention(s): BAT4406F
Locations: Huashan Hospital affiliated to Fudan University, Shanghai, Shanghai, China
A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum Disorders
Status: Recruiting
Last Changed: Mar 04, 2020
First Received: Nov 06, 2017
Disease(s): Neuromyelitis Optica Spectrum Disorders
Intervention(s): Placebo, RC18 160 mg
Locations: Beijing Hospital, Beijing, Beijing, China
Clinical Patterns of Neuromyelitis Optica Spectrum Disorders in Assiut University Hospital
Status: Recruiting
Last Changed: May 21, 2020
First Received: Jan 28, 2019
Disease(s): Neuromyelitis Optica Spectrum Disorder
Intervention(s): serum aquaporin 4 antibody (AQP-4-Ab), serum MOG antibody (anti-MOG), MRI brain, spine and orbit
Locations: Assiut University Hospital, Assiut, Egypt
Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum Disorders
Status: Not yet recruiting
Last Changed: Aug 22, 2019
First Received: Aug 22, 2019
Disease(s): Neuromyelitis Optica Spectrum Disorder
Intervention(s): blood purification equipment
An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit
Status: Not yet recruiting
Last Changed: May 14, 2020
First Received: May 14, 2020
Disease(s): Neuromyelitis Optica Spectrum Disorders
Locations: Department of Neurology,First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD
Status: Recruiting
Last Changed: Jun 04, 2020
First Received: Dec 17, 2019
Disease(s): Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder
Intervention(s): Ravulizumab
Locations: University of Alabama Birmingham - Multiple Sclerosis Center, Birmingham, Alabama, United States
University of South Alabama, Mobile, Alabama, United States
North County Neurology Associate, Carlsbad, California, United States
University of Colorado Hospital Anschutz Outpatient Pavilion, Aurora, Colorado, United States
Advanced Neurosciences Research, LLC, Fort Collins, Colorado, United States
... and 19 other locations.
A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder
Status: Recruiting
Last Changed: Apr 20, 2020
First Received: Nov 07, 2019
Disease(s): Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder
Intervention(s): Eculizumab
Locations: Meridian Clinical Research, Rockville, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Yokohama City University Medical Center, Yokohama, Japan
Seoul National University Hospital, Seoul, Korea, Republic of
Hospital Sant Joan de Deu, Barcelona, Spain
... and 1 other locations.
The French Cohort and Biobank of Devic's Neuromyelitis Optica and Related Neurological Disorders (NMOSD) (NOMADMUS)
Status: Recruiting
Last Changed: Feb 11, 2020
First Received: Aug 01, 2016
Disease(s): Neuromyelitis Optica Spectrum Disorders, Neuromyelitis Optica Spectrum Related Disorders
Locations: Hospices Civils de Lyon / Hopital Neurologique Pierre Wertheimer, Bron, France
Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
Status: Recruiting
Last Changed: Aug 09, 2016
First Received: Jul 19, 2016
Disease(s): Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders
Intervention(s): Magnetic Resonance Imaging
Locations: Chinese PLA General Hospital, Beijing, Beijing, China
A Study of HBM9161 in NMOSD Patients
Status: Recruiting
Last Changed: May 18, 2020
First Received: Jan 13, 2020
Disease(s): NMO Spectrum Disorder
Intervention(s): HBM9161 Injection
Locations: Nanfang Hospital, Guangzhou, Guangdong, China